Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$568K Buy
4,420
+1,352
+44% +$158K 0.21% 77
2026
Q1
$369K Buy
3,068
+23
+0.8% +$2.65K 0.15% 86
2025
Q4
$321K Sell
3,045
-866
-22% -$81.3K 0.13% 91
2025
Q3
$328K Sell
3,911
-18
-0.5% -$1.48K 0.14% 94
2025
Q2
$311K Buy
3,929
+1,573
+67% +$125K 0.15% 96
2025
Q1
$211K Sell
2,356
-1,294
-35% -$121K 0.11% 110
2024
Q4
$363K Buy
3,650
+91
+3% +$9.38K 0.19% 69
2024
Q3
$404K Sell
3,559
-24
-0.7% -$2.85K 0.22% 60
2024
Q2
$444K Sell
3,583
-592
-14% -$76.3K 0.25% 50
2024
Q1
$551K Sell
4,175
-538
-11% -$66.3K 0.33% 41
2023
Q4
$514K Sell
4,713
-1,822
-28% -$189K 0.34% 43
2023
Q3
$673K Sell
6,535
-460
-7% -$49.6K 0.48% 41
2023
Q2
$807K Sell
6,995
-585
-8% -$66.4K 0.56% 33
2023
Q1
$806K Buy
7,580
+213
+3% +$23K 0.58% 30
2022
Q4
$817K Buy
7,367
+2,583
+54% +$264K 0.64% 33
2022
Q3
$433K Buy
4,784
+667
+16% +$59.5K 0.37% 63
2022
Q2
$375K Buy
4,117
+177
+4% +$15.7K 0.33% 68
2022
Q1
$323K Buy
3,940
+593
+18% +$46.8K 0.25% 73
2021
Q4
$256K Buy
3,347
+1
+0% +$80 0.2% 92
2021
Q3
$251K Buy
3,346
+42
+1% +$3.19K 0.21% 97
2021
Q2
$257K Sell
3,304
-112
-3% -$8.33K 0.22% 97
2021
Q1
$251K Buy
3,416
+1
+0% +$74 0.24% 85
2020
Q4
$267K Buy
+3,415
New +$261K 0.26% 81

Other funds holding MRK

MRA Advisory Group's MRK Position: Q2 2026 in Review

MRA Advisory Group increased its Merck (MRK) stake by 44% in Q2 2026, buying an estimated $158K and bringing the position to 4,420 shares worth $568K. The position accounts for 0.21% of the portfolio, ranked #77.

MRA Advisory Group first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $817K in Q4 2022. 1,303 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • MRA Advisory Group held 4,420 shares of Merck worth $568K as of Q2 2026.
  • MRA Advisory Group bought 1,352 Merck shares in Q2 2026, an estimated $158K.
  • Merck made up 0.21% of MRA Advisory Group's portfolio in Q2 2026, its #77 holding.
  • MRA Advisory Group first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • MRA Advisory Group's Merck position peaked at $817K in Q4 2022.
  • 1,303 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on MRA Advisory Group's 13F filing for Q2 2026, filed 8 Jul 2026.